Can You Buy Neuralink Stock Before the IPO?

This page contains links to our partners. RBD may be compensated when a link is clicked. Read disclosures.

Neuralink logo. Article for those interested in Neuralink stock and ipo

Learn about potential ways to acquire Neuralink stock before and during the IPO. Buy and sell shares of private companies at Hiive. Sign up to monitor share availability and place bids on target pre-IPO startups so sellers can find you.

Non-accredited investors can access select pre-IPO startups via the Fundrise Innovation Fund

Neuralink — Recent News

05/20/2024: Neuralink Gets FDA Green Light for Second Patient
05/08/2024: PRIME Study Progress Update
03/20/2024: Neuralink users moves computer mouse with brain
01/29/2024: Neuralink implants brain tech in 1st human patient
More news…

What is Neuralink?

Neuralink is a medical device company aiming to build a fully integrated brain-machine interface (BMI), also known as a brain-computer interface (BCI).

The technology has the potential to treat people with disabilities of the brain and spine, including paralysis, blindness, deafness, memory loss, stroke, and more. 

Developing treatments for these disorders could dramatically improve millions of people’s lives and lead to considerable profits for the company.

Fans of Elon Musk realize that he will likely become one of the most consequential technologists and entrepreneurs of our lifetimes.

He’s started several companies, cashing out of earlier ventures to build companies that tackle humanity’s biggest challenges, including transportation, climate change, and becoming a multi-planet species.

Neuralink is his next ‘crazy idea’ to link the power of artificial intelligence with nature’s most complex and intelligent organ, the human brain. 

Science fiction fans might hear implantable brain devices and think it’s the first step toward human/AI symbiosis, as seen in fiction such as The 100 and Altered Carbon.

The surgery will be more invasive than BCI competitor Synchron’s device which is implanted through the jugular vein in the neck. 

Musk’s ultimate goal could be to empower humans to stay equal to or ahead of artificial intelligence. However, that’s a long way off. And Musk needs to create a profitable business first. 

As of today, Neuralink is in startup mode, having assembled a team of neuroscientists and medical experts to pursue this challenging endeavor. 

To date (June 2023), the company has raised more than $360 million, primarily from Elon Musk, and a Series C round in July 2021.

Neuralink is based in San Francisco and has about 100 employees. 

Neuralink Videos

On January 31st, 2021, Elon Musk tweeted to encourage people to apply to work at Neuralink, sharing a video about brain surgery robots. 

Here’s the video:

Here is a monkey with a Neuralink implant playing pong:

Is Neuralink Stock Publicly Traded?

No, the company is not publicly traded. It’s primarily funded by Musk and venture capital investors. 

Who Owns Neuralink?

High-profile investors involved in the company who may also retain some equity include Flip Sabes, Ben Rapoport, DJ Seo, Paul Merolla, Vanessa Tolosa, Max Hodak, Tim Hanson, and Tim Gardner. 

Prominent venture capital investors include Vy Capital, Google Ventures, DFJ Growth, Valor Equity Partners, Craft Ventures, Founders Fund, and Gigafund.

Musk’s extraordinary growth in wealth, thanks to the rise of Tesla stock, means he could easily continue to fund Neuralink operations without venture capital. 

When the time comes to scale, Musk has proven he is willing to take on venture capital funds or take companies public to spread risk and add value to his equity holdings.

However, he would unlikely take Neuralink public without a product or near-term means to generate revenue.

Neuralink is also developing a robotic implant device and procedure, which could become a marketable product by itself. Other potential revenue sources may include intellectual property and data. 

Neuralink Funding Rounds

Round Date Est. Valuation Raise Amount Price/Shr
Series D 11/21/23 $3.52B $323.24M $19.03
Later Stage VC 07/07/23 $3.48B $280.00M $19.03
Series C 07/29/21 $2.11B $205.90M $13.74
Series B 06/27/19 $522.00M $51.00M $3.82
Early Stage VC 08/23/17 NA $107.00M NA
Souce: Caplight
WordPress Table

What is the Neuralink Valuation?

The Neuralink valuation is about $5 billion, according to reporting by Reuters. This estimate is as of June 2023 and based on private stock trades described to Reuters.

Private market data provided by Hiive from late 2023 and early 2024 suggest the the valuation is closer to $6 billion.

We later learned that Neuralink completed a Series D funding round, as announced by the company in a tweet on August 7th, 2023. Its Series D fundraising round raised $280 million and was led by Peter Thiel’s Founders Fund.

The recent $5 billion valuation is up from the $2 billion Neuralink valuation established in 2021 when it completed its Series C funding round. 

When is the Neuralink IPO date?

The Neuralink IPO date is currently unknown. The company is still in the early phases of technology development. 

Commercialization of its technology could be a decade away. 

Private funding from Musk has covered its employee and development costs so far. Considering Musk’s reputation as a business builder, additional private funding rounds would be possible before an IPO. 

However, since Musk is the primary equity holder and lacks the need for liquidity, a Neuralink IPO is unlikely within the next few years. 

If the company becomes viable and eventually profitable, we’ll likely hear about a potential filing well before it is submitted. 

Even when the company and SEC publicly release the S-1 filing, we still won’t know a firm date. However, the IPO date typically occurs a month or two after the S-1 is released to the public.

Because Musk’s name is synonymous with Neuralink, you can be sure that any rumblings of a Neuralink IPO will be widely publicized among financial news and medical technology news outlets. 

What is the Neuralink Stock Price?

Since Neuralink is not publicly traded on a stock exchange, there is no public Neuralink stock price yet.

The November Series D share price was about $19 per share. Private market data provided by Hiive indicate share traded hands in the $34-$38 range in December 2023 and January 2024. 

What is the Neuralink Stock Symbol?

Neuralink has not yet submitted public filings to the Securities and Exchange Commission. Therefore, it is not yet known what the Neuralink stock symbol will be. We can only speculate about the Neuralink ticker.

Here are some suggestions, all of which appear to be available in the U.S.:

  • LINK
  • NLNK
  • LNK

Can you Buy Neuralink Stock? Three Potential Ways

It is challenging to buy shares of a stock that doesn’t trade on the public markets. Even if possible, you may not be eligible, and it may not be worth the hassle. 

In Neuralink’s case, acquiring pre-IPO shares is likely even more difficult because Musk maintains most of the equity holdings.

With that in mind, aspiring investors need to be extraordinarily patient and may not be eligible to invest for many years or possibly ever. 

Here are three ways investors can attempt to acquire shares of a pre-IPO stock. 

1. Buy Shares via Pre-IPO Marketplaces

The author has observed multiple instances of Neuralink stock being available on pre-IPO marketplaces. Hiive is one of the more active platforms. Sign up to monitor the latest availability.  

Founders, early employees, and investors are often in a difficult predicament. They own valuable shares of a company that doesn’t trade publicly. 

These shareholders might have multi-million dollar net worths because of their stock holdings, but the stock is not liquid because it doesn’t trade on an exchange. 

A few platforms have evolved to give these individuals a way to liquidate their holdings before the IPO.

Prominent pre-IPO platforms include Equitybee, Hiive, Linqto, EquityZen, and Forge Global. Learn more about pre-IPO investing platforms. 

These sites bring liquidity to an otherwise illiquid asset. Accredited investors may join these sites and attempt to buy shares of these companies when they become available. 

The shares are only offered to accredited investors because their financials are not publicly filed with regulators yet, increasing the investors’ risk.

Non-accredited investors can sidestep the accreditation requirement to invest in pre-IPO startups by owning the Fundrise Innovation Fund. However, Neuralink is not a current holding. Monitor the fund for new pre-IPO investments. 

For high-profile companies, demand is high, lowering your chances of acquiring shares, even if you’re accredited. 

Please note: This is a testimonial in partnership with Fundrise. We earn a commission from partner links on All opinions are my own.

2. Buy Stock in the Neuralink Initial Public Offering (IPO)

Ambitious investors may attempt to position themselves to invest in the Neuralink IPO before it happens. Most retail investors will not get access.

The wealthiest clients at the top investment banks will get IPO shares in the hottest deals.

Your chances of getting IPO shares depend on four factors:

  • IPO demand
  • Your broker and eligibility
  • Your assets under management at the broker
  • Propensity to flip shares

As IPO demand increases, the chances of receiving IPO shares decrease. Therefore, the IPOs that are most interesting to the masses are the hardest to access. 

Lower-demand IPOs may be available to retail investors who are customers of participating brokers. 

What are the Best Online Brokers for IPO Investing?

For an extensive list of IPO-friendly online brokers and their eligibility, check out this page.

Wealthy customers ($1 million+ accounts) at Fidelity, TD Ameritrade, and Schwab may have a shot at some IPOs, depending on demand. 

TradeStation is the best option for investors with less than $250,000. It gives limited access to lower-demand IPOs and secondary offerings through a partnership with ClickIPO, an IPO investing app.

Joining a broker that offers access to IPOs does not guarantee a share allocation, especially in high-demand IPOs. You are probably better off waiting for the company to start trading after the IPO. 

3. Buy After the IPO

Since acquiring pre-IPO shares is delicate and usually reserved for wealthy investors, the most likely way you’ll ever own the stock is to wait patiently for the IPO to complete. 

In many cases, investors can get in at a price at or below the IPO price. This is not always true.

Uber, which many predicted to rise steeply, actually fell on the IPO date.

The moral here is that spending significant effort to own a company before the IPO may not be worth it in the end.

You may also spend time and effort to obtain shares but only receive a small allocation. Even if the stock soars, your upside gain may be limited.

Your best chance to own the stock is by waiting for the IPO and making a purchase of Neuralink stock through a no-fee online brokerage account. You can open the account well before the IPO, then place your first trade to learn how to buy shares. 

I recommend starting with a company you know well. If you like Target, for example, buy Target stock.

So what is the best online brokerage for buying Neuralink stock?

As an individual investor, you’ll want to open an account with a commission-free online broker. That way, you’ll invest most of your money instead of wasting it on fees.

I’ll go over one of my favorites below. It has very reasonable fees and will make it easy to buy Neuralink stock once it begins trading on open stock markets. 

Neuralink News Archive

11/25/2023: Neuralink quietly raises an additional $43M
11/07/2023: Musk’s Brain Implant Startup Is Ready to Start Surgery
09/19/2023: Neuralink’s First-in-Human Clinical Trial is Open
08/07/2023: Neuralink raises $280 million in Series D
06/25/2023: Exclusive: Musk’s Neuralink valued at about $5 billion
05/25/2023: Neuralink says it has FDA approval for human trials
03/27/2023: Neuralink in search of human trials partner
02/11/2023: Neuralink is under investigation
11/30/2022: Neuralink “Show and Tell” Today at 6pm PST, 9pm EST
08/19/2022: Musk approaches Synchron about deal amid Neuralink delays
07/07/2022: Fortune: Neuralink reality check
05/03/2022: Why Neuralink, not Twitter, is Elon Musk’s biggest challenge
04/08/2022: Elon Musk says humans could eventually download their brains into robots
01/20/2022: Brain chip firm Neuralink lines up clinical trials in humans
12/22/2021: Elon Musk Says the Metaverse Sucks and Neuralink Will Be Better
12/07/2021: Elon Musk sees human Neuralink implants for 2022
07/30/2021: Series C funding round announcement
05/01/2021: Neuralink Co-Found Leaves Company for Unknown Reasons
04/08/2021: Musk Tweets: “First @Neuralink product will enable someone with paralysis to use a smartphone with their mind faster than someone using thumbs”
02/01/2021: Elon Musk says his startup Neuralink has wired up a monkey to play video games
01/31/2021: Neuralink is Hiring (Elon Musk Tweets Robot Video – see below)
12/24/2020: Elon Musk said that combining SpaceX, Tesla, Neuralink, and Boring under a megacorporation called ‘X’ would be a ‘good idea’
09/27/2020: The State of Brain-Computer Interface and Neuralink
09/09/2020: Why Is Elon Musk Testing His Brain Implant on Pigs?
09/03/2020: Neuralink Is Impressive Tech, Wrapped in Musk Hype
09/03/2020: Elon Musk’s Neuralink Looks to Expand Beyond Silicon Valley to Texas
08/29/2020: Neuralink: Elon Musk unveils pig with a chip in its brain


It will be difficult for ordinary investors to acquire shares of Neuralink before or during the IPO. It’s a private company with no products or revenue. 

That doesn’t stop people from wanting to invest with arguably the greatest business builder of our time. 

If you’re determined, follow the pre-IPO marketplaces and pay attention to any offerings. Investor accreditation is required. 

Otherwise, you’ll need to wait for the IPO date to buy shares. An IPO is not imminent. 

Waiting is OK. Neuralink has a very high chance of failure. If the science pans out, expect to see lookalikes aiming to compete. 

When the Neuralink IPO is near, please perform due diligence on the SEC S-1 filing and don’t buy Neuralink stock with money you can’t afford to lose. 

Disclosure: This web page contains affiliate links from our partners. If a reader opens an account or buys a service from a link in this article, we may be compensated at no additional cost to the reader. Opening an account with a broker that provides access to IPOs does not guarantee the customer will receive share allocations of specific IPOs. The author is long TSLA, TGT, and the ARK Venture Fund. 

Favorite tools and investment services right now:

Sure Dividend — Download the free Dividend Kings list, 50+ stocks with 50+ consecutive years of dividend increases. (review)

Fundrise — Simple real estate and venture capital investing for as little as $10. (review)

NewRetirement — Spreadsheets are insufficient. Get serious about planning for retirement. (review)

M1 Finance — A top online broker for long-term investors and dividend reinvestment. (review)